Stay updated with breaking news from Tracy Olsten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In clinical trials, Tzield delayed progression to full-blown diabetes by a little over two years. But the benefits have lasted much longer in some of the study participants.
A biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.
FRIDAY, Nov. 18, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of type 1 diabetes (T1D).
A biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.